SNOA
Price
$2.97
Change
+$0.05 (+1.71%)
Updated
Jul 3 closing price
Capitalization
2.39M
TAK
Price
$15.34
Change
-$0.08 (-0.52%)
Updated
Jul 3 closing price
Capitalization
43.11B
24 days until earnings call
Interact to see
Advertisement

SNOA vs TAK

Header iconSNOA vs TAK Comparison
Open Charts SNOA vs TAKBanner chart's image
Sonoma Pharmaceuticals
Price$2.97
Change+$0.05 (+1.71%)
Volume$23.56K
Capitalization2.39M
Takeda Pharmaceutical
Price$15.34
Change-$0.08 (-0.52%)
Volume$1.65M
Capitalization43.11B
SNOA vs TAK Comparison Chart in %
Loading...
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNOA vs. TAK commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNOA is a Hold and TAK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (SNOA: $2.97 vs. TAK: $15.34)
Brand notoriety: SNOA and TAK are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SNOA: 48% vs. TAK: 82%
Market capitalization -- SNOA: $2.39M vs. TAK: $43.11B
SNOA [@Pharmaceuticals: Other] is valued at $2.39M. TAK’s [@Pharmaceuticals: Other] market capitalization is $43.11B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNOA’s FA Score shows that 0 FA rating(s) are green whileTAK’s FA Score has 2 green FA rating(s).

  • SNOA’s FA Score: 0 green, 5 red.
  • TAK’s FA Score: 2 green, 3 red.
According to our system of comparison, TAK is a better buy in the long-term than SNOA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNOA’s TA Score shows that 6 TA indicator(s) are bullish while TAK’s TA Score has 6 bullish TA indicator(s).

  • SNOA’s TA Score: 6 bullish, 4 bearish.
  • TAK’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SNOA is a better buy in the short-term than TAK.

Price Growth

SNOA (@Pharmaceuticals: Other) experienced а +3.48% price change this week, while TAK (@Pharmaceuticals: Other) price change was +1.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

TAK is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($43.1B) has a higher market cap than SNOA($2.39M). TAK YTD gains are higher at: 15.861 vs. SNOA (10.409). TAK has higher annual earnings (EBITDA): 1.01T vs. SNOA (-4.27M). TAK has more cash in the bank: 317B vs. SNOA (2.41M). SNOA has less debt than TAK: SNOA (385K) vs TAK (4.66T). TAK has higher revenues than SNOA: TAK (4.17T) vs SNOA (12.3M).
SNOATAKSNOA / TAK
Capitalization2.39M43.1B0%
EBITDA-4.27M1.01T-0%
Gain YTD10.40915.86166%
P/E RatioN/A36.79-
Revenue12.3M4.17T0%
Total Cash2.41M317B0%
Total Debt385K4.66T0%
FUNDAMENTALS RATINGS
SNOA vs TAK: Fundamental Ratings
SNOA
TAK
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
10
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9885
PRICE GROWTH RATING
1..100
5751
P/E GROWTH RATING
1..100
6319
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (10) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNOA (63) in the Pharmaceuticals Other industry. This means that TAK’s stock grew somewhat faster than SNOA’s over the last 12 months.

TAK's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as SNOA (100) in the Pharmaceuticals Other industry. This means that TAK’s stock grew similarly to SNOA’s over the last 12 months.

TAK's SMR Rating (85) in the Pharmaceuticals Major industry is in the same range as SNOA (98) in the Pharmaceuticals Other industry. This means that TAK’s stock grew similarly to SNOA’s over the last 12 months.

TAK's Price Growth Rating (51) in the Pharmaceuticals Major industry is in the same range as SNOA (57) in the Pharmaceuticals Other industry. This means that TAK’s stock grew similarly to SNOA’s over the last 12 months.

TAK's P/E Growth Rating (19) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNOA (63) in the Pharmaceuticals Other industry. This means that TAK’s stock grew somewhat faster than SNOA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNOATAK
RSI
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
47%
Momentum
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
40%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
38%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
43%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
38%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
43%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend 20 days ago
44%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TAOP4.480.41
+10.07%
Taoping Inc
QUBT21.130.48
+2.32%
Quantum Computing
NEO7.550.15
+2.03%
NeoGenomics
GLRE14.320.17
+1.20%
Greenlight Capital Re Ltd
SARO30.88-0.09
-0.29%
StandardAero Inc

SNOA and

Correlation & Price change

A.I.dvisor tells us that SNOA and ASRT have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNOA and ASRT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNOA
1D Price
Change %
SNOA100%
+1.71%
ASRT - SNOA
26%
Poorly correlated
-3.23%
OGI - SNOA
26%
Poorly correlated
+3.62%
TAK - SNOA
24%
Poorly correlated
-0.52%
LFCR - SNOA
21%
Poorly correlated
N/A
ZTS - SNOA
21%
Poorly correlated
+0.06%
More

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with HLN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
-0.52%
HLN - TAK
40%
Loosely correlated
-0.10%
RDY - TAK
25%
Poorly correlated
+1.34%
SNOA - TAK
24%
Poorly correlated
+1.71%
EOLS - TAK
23%
Poorly correlated
+0.65%
KHTRF - TAK
22%
Poorly correlated
+4.50%
More